SCHEMBL10464668

SCHEMBL10464668

O=C(O)CN1C(=O)/C(=C\c2cccs2)SC1=S

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.74
▸ LMNA P02545 1/20 0.65
▸ KMT2A Q03164 4/20 0.64
▸ MAPT P10636 3/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ PTPN12 Q05209 1/20 0.62
▸ PTPN22 Q9Y2R2 1/20 0.62
▸ MEN1 O00255 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ POLB P06746 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ MMP3 P08254 1/20 0.60
▸ AKR1B1 P15121 1/20 0.60
▸ PTPN1 P18031 1/20 0.60
▸ MMP13 P45452 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6885409 1.00 FFAR1 (0.74) FFAR1LMNAKMT2AMAPTTDP1
SCHEMBL6885407 1.00 FFAR1 (0.74) FFAR1LMNAKMT2AMAPTTDP1
SCHEMBL12008950 0.87 FFAR1 (0.86) FFAR1LMNAKMT2AMAPTMEN1
SCHEMBL20534434 0.86 KDR (0.66) FFAR1KMT2AMAPTMEN1POLB
SCHEMBL20534435 0.86 KDR (0.66) FFAR1KMT2AMAPTMEN1POLB
SCHEMBL12006896 0.85 FFAR1 (1.00) FFAR1LMNAKMT2AMAPTTDP1
SCHEMBL1901692 0.85 PTPN22 (0.61) FFAR1KMT2AMAPTPTPN12PTPN22
SCHEMBL1901689 0.85 PTPN22 (0.61) FFAR1KMT2AMAPTPTPN12PTPN22
SCHEMBL1901690 0.85 PTPN22 (0.61) FFAR1KMT2AMAPTPTPN12PTPN22
SCHEMBL13056346 0.83 PTPN22 (0.67) KMT2AMAPTPTPN12PTPN22MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4831045-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 — — US claimed
EP-0047109-B1 RHODANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND ALDOSE REDUCTASE INHIBITOR CONTAINING THE RHODANINE DERIVATIVES AS ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 — — EP claimed
EP-0047109-A1 Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1982-03-10 — — EP claimed
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 — — US disclosed
US-4831045-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 — — US disclosed
US-4791126-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients ONO PHARMACEUTICAL CO., LTD. (JP) 1988-12-13 — — US disclosed
EP-0047109-B1 RHODANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND ALDOSE REDUCTASE INHIBITOR CONTAINING THE RHODANINE DERIVATIVES AS ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 — — EP disclosed
US-4464382-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1984-08-07 — — US disclosed
EP-0047109-A1 Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1982-03-10 — — EP disclosed
Send feedback